Brief: Karolinska Development's Portfolio Company OssDsign Reports Favourable Outcome Data On OSSDSIGN Cranial PSI

OssDsign AB

07/11/2019 15:04

Nov 7 (Reuters) - Karolinska Development AB  KDEV.ST :
    * KAROLINSKA DEVELOPMENT’S PORTFOLIO COMPANY OSSDSIGN
REPORTS
FAVOURABLE OUTCOME DATA ON OSSDSIGN CRANIAL PSI
    * RELEASED UPDATED OUTCOME DATA WHICH REVEALS THAT RATE OF
INFECTIONS LEADING TO IMPLANT REMOVAL OF OSSDSIGN CRANIAL PSI
REMAINED LOW (2.4%) AFTER A MEDIAN FOLLOW-UP TIME OF 17 MONTHS
    * OSSDSIGN POST-MARKET-SURVEILLANCE DATA HOWEVER SHOWS THAT
AT A
MEDIAN FOLLOW UP TIME OF 17 MONTHS (RANGE: 0-58 MONTHS) ONLY 16
(2.4%) OF IMPLANTS WERE EXPLANTED DUE TO EARLY POSTOPERATIVE
INFECTIONS

Source text for Eikon:  ID:nGNEbbwbrh 
Further company coverage:  KDEV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))